Tandem HILIC-IMAC strategy for simultaneous N-glycoproteomics and phosphoproteomics in aging mouse brain.

Xinlian Ding, Danyi Shang, Yun Cui, Xuefang Dong, Cheng Chen, Yanyan Zhao, Xiuling Li, Xinmiao Liang

Pharmacy College, Dalian Medical University, Dalian, 116044, PR China; Key Laboratory of Phytochemistry and Natural Medicines. Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, PR China; Ganjiang Chinese Medicine Innovation Center, Nanchang, 330000, PR China.Pharmacy College, Dalian Medical University, Dalian, 116044, PR China; Key Laboratory of Phytochemistry and Natural Medicines. Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, PR China; Ganjiang Chinese Medicine Innovation Center, Nanchang, 330000, PR China. · pubmed

Paper

Abstract

Abnormal glycosylation and phosphorylation are strongly associated with brain aging. N-glycosylation and phosphorylation are closely involved in pathological processes in a crosstalk dependent manner. However, simultaneous characterization of glycosylation and phosphorylation together in aging brain was uncommon. Herein we developed a novel tandem HILIC-IMAC strategy for simultaneous analysis of N-glycoproteomics and phosphoproteomics. This tandem method showed higher enrichment repeatability, more identifications of glycopeptides and phosphopeptides, and lower overlap. Application of the established method to mouse brain at two ages (8 weeks and 65 weeks) to explore changes in glycosylation and phosphorylation during aging. Up to 10,990 N-glycopeptides and 11,409 phosphopeptides were identified from mouse brain. Among these, differentially expressed phosphoproteins were involved in regulation of microtubule depolymerization, synapse, and transmission of nerve impulse. And glycoproteins differentially expressed with age were mostly related to cell adhesion processes and extracellular matrix. Furthermore, we found the opposite expression trends in glycosylation and phosphorylation during aging on Grin2b. Together, the HILIC-IMAC strategy has potential to discover aging biomarkers and analyze complex biosamples, paving the way for in-depth investigations for the changes of protein glycosylation and phosphorylation in aging brain.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses the simultaneous analysis of N-glycoproteomics and phosphoproteomics in the context of aging, which is relevant to understanding the biological processes associated with aging. However, while it presents a novel methodology and identifies changes in glycosylation and phosphorylation in the aging mouse brain, the findings are more incremental in nature rather than groundbreaking. The study contributes to the field by providing a new analytical approach, but it does not directly address the root causes of aging or propose significant interventions for lifespan extension or age-related diseases.

Author of this paper? Send a correction.